JNK1/2/3 Recombinant Antibody

$25 ug total protein per lane of various lysates (see on figure) probed with JNK1\/2\/3 monoclonal antibody, unconjugated (bsm-62901R) at 1:2000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.$

25 ug total protein per lane of various lysates (see on figure) probed with JNK1\/2\/3 monoclonal antibody, unconjugated (bsm-62901R) at 1:2000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.

Applications

WB
IP
ICC/IF

Reactivity

Human
Mouse
Rat

Predicted Reactivity

Dog
Cow
Zebrafish
Monkey

Overview
Catalog #	bsm-62901r
Product Name	JNK1/2/3 Recombinant Antibody
Applications	WB, IP, ICC/IF
Reactivity	Human, Mouse, Rat
Predicted Reactivity	Dog, Cow, Zebrafish, Monkey
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	KLH conjugated synthetic peptide derived from human JNK1
Clonality	Recombinant
Isotype	IgG
Concentration	Lot dependent
Purification	Purified by Protein A.
Storage Buffer	0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Storage Condition	Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID	5599
Swiss Prot	P45983,P45984,P53779
Synonyms	c-Jun N-terminal kinase 3; JNK1; JNK2;JNK3; JNK3 alpha protein kinase; JNK3A; MAP kinase 10; MAP kinase p49 3F12; MAPK 10; MAPK10.
Background	Serine/threonine-protein kinase involved in various processes such as cell proliferation, differentiation, migration, transformation and programmed cell death. Extracellular stimuli such as proinflammatory cytokines or physical stress stimulate the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway.
Application Dilution
WB	1:300-5000
IP	1-2ug
ICC/IF	1:50-100